Membrane type 1 matrix metalloproteinase regulates cellular invasiveness and survival in cutaneous epidermal cells

Journal of Investigative Dermatology

Volumn 118, Issue 4, 2002, Pages 573-581

  Nagavarapu, Usha ^a   Relloma, Kenneth ^a   Herron, G Scott ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell survival; Matrix metalloprotinase 2; Membrane type 1 matrix metalloproteinase; Migration

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; MATRIX METALLOPROTEINASE 14;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; EPIDERMIS CELL; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION;

EID: 0036223972     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.01713.x     Document Type: Article

References (52)

1. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes
2. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter
3. Proteolytic remodeling of extracellular matrix
4. Matrix Metalloproteinases: A review
5. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
6. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity
7. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds
8. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
9. Membrane-type matrix metalloproteinases in human dermal microvascular endothelial cells: Expression and morphogenetic correlation
10. Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes
11. Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C anti-sense prevents progression, of vascular disease
12. Matrix metalloproteinases in tumor invasion and metastasis
13. Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase
14. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells
15. Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate anti-sense oligodeoxynucleotides is the consequence of anti-sense-specific and anti-sense-non-specific effects
16. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins
17. Coexpression of integrin αvβ3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: Correlation with melanoma progression
18. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
19. Molecular genetics and target site specificity of retroviral integration
20. Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen
21. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice
22. Phosphorothioate oligonucleotides reduce melanoma growth in a SCID-hu mouse model by a nonantisense mechanism
23. Matrix metalloproteinases and their inhibitors in tumour growth and invasion
24. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads
25. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus
26. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by anti-sense gene transfer impairs glioblastoma cell invasion
27. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5
28. Matrix metalloproteinases (MMP) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair
29. Matrix metalloproteinases
30. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion
31. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
32. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas
33. Expression of matrix metalloproteinases during rat skin wound healing: Evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A
34. Matrix metalloproteinases in repair
35. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
36. Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype
37. Localization of messenger RNA for Mr 72, 000 and 92, 000 type IV collagenases in human skin cancers by in situ hybridization
38. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen
39. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
40. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides
41. A matrix metalloproteinase expressed on the surface of invasive tumour cells
42. Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts
43. Neutrophil-derived serine proteinases enhance membrane type-1 matrix metalloproteinase-dependent tumor cell invasion
44. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
45. Extracellular matrix 6: Role of matrix metalloproteinases in tumor invasion and metastasis
46. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
47. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation
48. ECM and cell surface proteolysis: Regulating cellular ecology
49. Regulation of matrix metalloproteinase expression in tumor invasion
50. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing
51. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I
52. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP)